Find a Trial

Trial Summary


Protocol No.CTO-SWOG-S1904
StatusOPEN TO ACCRUAL
Principal InvestigatorBallinger, Tarah
ScopeLocal
PhaseNA
Age GroupAdult
TitleCLUSTER RANDOMIZED CONTROLLED TRIAL OF PATIENT AND PROVIDER DECISION SUPPORT TO INCREASE CHEMOPREVENTION INFORMED CHOICE AMONG WOMEN WITH ATYPICAL HYPERPLASIA OR LOBULAR CARCINOMA IN SITU - MAKING INFORMED CHOICES ON INCORPORATING CHEMOPREVENTION INTO CARE (MiCHOICE)
DescriptionThis trial studies the implementation of web-based decision support tools for patients with atypical hyperplasia or lobular carcinoma in situ and healthcare providers. Decision support tools are designed to improve informed choice about breast cancer chemoprevention. Recognizing barriers and facilitators that can influence the adoption of decision support tools at recruitment centers may help researchers learn how to best implement them into clinical practice.
Key Eligibility

In order to be eligible to take part in this trial, patients must meet the following criteria:

  • Patients must have histologically-confirmed atypical hyperplasia (AH) or lobular carcinoma in situ (LCIS) documented by breast pathology report at any time in the past. Patients with borderline breast lesions and pleomorphic LCIS are also eligible
  • Patients must be women at least 35 and no more than 74 years of age at registration, since the Breast Cancer Surveillance Consortium (BCSC) risk calculator is valid only for this age range

For a full list of participation criteria, please visit clinicaltrials.gov.

Applicable Disease SitesBreast
Participating InstitutionsIndiana University (IU)
    Treatment TypeOther
    ContactPhone: (317) 278-5632
    Email: iutrials@iu.edu